Showing results (31-40 of 177) with videos related to
Sort By:
Pageof 18
Journal of Pharmaceutical Sciences|January 26, 2006
Chemical kinetics and aqueous degradation pathways of a new class of synthetic ozonide antimalarialsChristine S Perry, Susan A Charman, Richard J Prankerd, et al.Journal of Pharmaceutical Sciences|November 30, 2005
The binding interaction of synthetic ozonide antimalarials with natural and modified beta-cyclodextrinsChristine S Perry, Susan A Charman, Richard J Prankerd, et al.Chemical Research in Toxicology|August 29, 2015
Evidence for the in vitro bioactivation of aminopyrazole derivatives: trapping reactive aminopyrazole intermediates using glutathione ethyl ester in human liver microsomesEileen Ryan, Benjamin J Morrow, Catherine F Hemley, et al.Antimicrobial Agents and Chemotherapy|February 13, 2008
Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarialsDarren J Creek, William N Charman, Francis C K Chiu, et al.Molecular Pharmaceutics|April 24, 2015
Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulationsYasemin Sahbaz, Hywel D Williams, Tri-Hung Nguyen, et al.Pharmacological Reviews|February 7, 2013
Strategies to address low drug solubility in discovery and developmentHywel D Williams, Natalie L Trevaskis, Susan A Charman, et al.Journal of Medicinal Chemistry|October 24, 2007
Spiro- and dispiro-1,2-dioxolanes: contribution of iron(II)-mediated one-electron vs two-electron reduction to the activity of antimalarial peroxidesXiaofang Wang, Yuxiang Dong, Sergio Wittlin, et al.Journal of Medicinal Chemistry|August 7, 2019
The Development Process for Discovery and Clinical Advancement of Modern AntimalarialsTrent D Ashton, Shane M Devine, Jörg J Möhrle, et al.Journal of Pharmaceutical Sciences|June 6, 2007
Iron-mediated degradation kinetics of substituted dispiro-1,2,4-trioxolane antimalarialsDarren J Creek, William N Charman, Francis C K Chiu, et al.Journal of Medicinal Chemistry|October 16, 2009
S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrasesMarie Lopez, Blessy Paul, Andreas Hofmann, et al.Pageof 18